« Previous
Next »
The Spine Journal
Volume 10, Issue 3
, Pages 212-218
, March 2010
Cytokine evaluation in individuals with low back pain using discographic lavage
References
- Expenditures and health status among adults with back and neck problems. JAMA. 2008;299:656–664
- Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation. J Bone Joint Surg Am. 1990;72:403–408
- . A gold standard evaluation of the “discogenic pain” diagnosis as determined by provocative discography. Spine. 2006;31:2115–2123
- 2000 Volvo Award winner in basic science studies: exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine. 2000;25:2975–2980
- A critical evaluation of discography in patients with lumbar intervertebral disc disease. Spine J. 2008;8:624–629
- High levels of inflammatory phospholipase A2 activity in lumbar disc herniations. Spine. 1990;15:674–678
- Neuropeptide converting enzyme activities in CSF of low back pain patients. Pain. 1990;43:163–168
- Neuropeptide-converting enzymes in cerebrospinal fluid: activities increased in pain from herniated lumbar disc, but not from coxarthrosis. Acta Orthop Scand. 1996;67:189–192
- Objective evaluation of pain in various spinal diseases: neuropeptide immunoreactivity in the cerebrospinal fluid. Spinal Cord. 1997;35:757–762
- mRNA expression of cytokines and chemokines in herniated lumbar intervertebral discs. Spine. 2002;27:911–917
- . Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica. Spine. 2001;26:863–869
- Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine. 1996;21:271–277
- Inflammatory cytokines in the herniated disc of the lumbar spine. Spine. 1996;21:218–224
- Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br. 2002;84:196–201
- . Epidural steroid injection for low back pain and sciatica: an updated systematic review of randomized clinical trials. Pain Digest. 1999;9:241–247
- Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine. 2001;26:1873–1878
- . The architecture of diagnostic research. BMJ. 2002;324:539–541
- Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol. 2003;10:133–139
- Lumbar discography in normal subjects. A controlled, prospective study. J Bone Joint Surg Am. 1990;72:1081–1088
- Comparison of discographic findings in asymptomatic subject discs and the negative discs of chronic LBP patients: can discography distinguish asymptomatic discs among morphologically abnormal discs?. Spine J. 2005;5:389–394
- A controlled immunohistochemical study of inflammatory cells in disc herniation tissue. Spine. 1994;19:2744–2751
- . The role of inflammation in disk herniation-associated radiculopathy. Semin Arthritis Rheum. 1998;28:60–71
- . Stereological analysis of Ca(2+)/calmodulin-dependent protein kinase II alpha-containing dorsal root ganglion neurons in the rat: colocalization with isolectin Griffonia simplicifolia, calcitonin gene-related peptide, or vanilloid receptor 1. J Comp Neurol. 2002;448:102–110
- Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur Spine J. 2002;11:62–66
- . Radicular pain—recent pathophysiologic concepts and therapeutic implications. Schmerz. 2001;15:425–429
- Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases. Spine. 1997;22:1065–1073
FDA device/drug status: not applicable.
Author disclosures: JMC (stock ownership, including options and warrants, Cytonics; scientific advisory board, Cytonics; research: staff/materials, Cytonics); SRG (stock ownership, including options and warrants, Cytonics Inc; scientific advisory board, Cytonics); MWR (stock ownership, including options and warrants, Cytonics; private investments, including venture capital, start-ups, Cytonics); VGC (stock ownership, including options and warrants, Cytonics Corp; scientific advisory board, Cytonics Corp); MSA (royalties, Stanford University; stock ownership, including options and warrants, Cytonics; consulting, Trigemina Inc, Cortex Inc, Vertex Inc; scientific advisory board, Cytonics Inc; research: investigator salary, Scientific Imaginetics; research: staff/materials, Scientific Imaginetics); EJC (consulting, Medtronic; scientific advisory board, Intrinsic Orthopedics, Cytonics; other office, Bioassetts; grants, AO Foundation; fellowship support, DePuy Spine); DCY (stock ownership, including options and warrants, Cytonics Inc; scientific advisory board, Cytonics, Inc); GJS (stock ownership, including options and warrants, Cytonics Corp; private investments, including venture capital, start-ups, K2 Medical; board of directors, Cytonics; scientific advisory board, Cytonics; other office, Chairman).
PII: S1529-9430(09)01127-9
doi: 10.1016/j.spinee.2009.12.007
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
The Spine Journal
Volume 10, Issue 3
, Pages 212-218
, March 2010
